Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
1994 9
1995 13
1996 14
1997 4
1998 12
1999 15
2000 7
2001 3
2002 7
2003 4
2004 9
2005 21
2006 17
2007 21
2008 23
2009 23
2010 22
2011 22
2012 30
2013 30
2014 33
2015 23
2016 15
2017 16
2018 13
2019 14
2020 13
2021 16
2022 14
2023 13
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Alpha emitter radium-223 and survival in metastatic prostate cancer.
Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators. Parker C, et al. N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755. N Engl J Med. 2013. PMID: 23863050 Free article. Clinical Trial.
Suprapubische Adenomektomie.
Kuczyk MA, Martinelli E. Kuczyk MA, et al. Aktuelle Urol. 2023 Apr;54(2):151-160. doi: 10.1055/a-1956-4517. Epub 2023 Apr 5. Aktuelle Urol. 2023. PMID: 37019139 German. No abstract available.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10. N Engl J Med. 2013. PMID: 23228172 Free PMC article. Clinical Trial.
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
Krilaviciute A, Becker N, Lakes J, Radtke JP, Kuczyk M, Peters I, Harke NN, Debus J, Koerber SA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Seibold P, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Giesel FL, Antoch G, Makowski M, Wacker F, Schlemmer HP, Kaaks R, Albers P. Krilaviciute A, et al. Among authors: kuczyk m. Eur Urol Oncol. 2023 Dec;6(6):566-573. doi: 10.1016/j.euo.2023.09.008. Epub 2023 Oct 6. Eur Urol Oncol. 2023. PMID: 37806841
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysis.
Faraj Tabrizi P, Zeuschner P, Katzendorn O, Schiefelbein F, Schneller A, Schoen G, Ubrig B, Gloger S, Wiesinger CG, Pfuner J, Falkensammer E, Eraky A, Osmonov D, Nuhn P, Zimmermanns V, Paramythelli I, Hadaschik BA, Radtke JP, Darr C, Gilbert N, Kriegmair M, Fuhrmann C, Kuczyk MA, Harke NN. Faraj Tabrizi P, et al. Among authors: kuczyk ma. Minerva Urol Nephrol. 2024 Dec;76(6):698-707. doi: 10.23736/S2724-6051.24.05816-6. Epub 2024 Nov 28. Minerva Urol Nephrol. 2024. PMID: 39607672 Free article.
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schröder FH, Albers P. Arsov C, et al. Among authors: kuczyk ma. Eur Urol. 2013 Dec;64(6):873-5. doi: 10.1016/j.eururo.2013.05.022. Epub 2013 May 14. Eur Urol. 2013. PMID: 23707067 No abstract available.
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial.
Al-Monajjed R, Boschheidgen M, Lakes J, Krilaviciute A, Radtke JP, Schlemmer HP, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Antoch G, Becker N, Kaaks R, Schimmöller L, Albers P. Al-Monajjed R, et al. Among authors: kuczyk ma. Eur Urol. 2025 Sep;88(3):240-244. doi: 10.1016/j.eururo.2025.05.020. Epub 2025 Jun 2. Eur Urol. 2025. PMID: 40461322 Free article. Clinical Trial.
436 results